Interest of sFlt1/PlGF Ratio at Obstetric Emergencies (NCT04170660) | Clinical Trial Compass
UnknownNot Applicable
Interest of sFlt1/PlGF Ratio at Obstetric Emergencies
France150 participantsStarted 2019-11-18
Plain-language summary
In patients with suspected placental vascular disease who do not require hospitalization, the use of the sFlt-1 (Soluble FMS like tyrosin-kinase-1)/PlGF (Placental Growth Factor)/ assay can most likely help teams to define the best possible management.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.